Mechanical ventilation has been shown to produce lung injury characterized
by noncardiogenic pulmonary edema, Keratinocyte growth factor (KGF) is a he
parin-binding growth factor that causes alveolar type II pneumocyte hyperpl
asia, KGF pretreatment and the resultant pneumocyte hyperplasia reduce flui
d flux in models of lung injury. We utilized the isolated perfused rat lung
model to produce lung injury by varying tidal volume and the level of posi
tive end-expiratory pressure during mechanical ventilation. Pretreatment wi
th KGF attenuated ventilator-induced lung injury (VILI). This was demonstra
ted by lower wet-to-dry lung weight ratios and less lung water accumulation
in the KGF group. Further, KGF prevented the decline in dynamic compliance
and alveolar protein accumulation in VILI, KGF pretreatment reduced alveol
ar accumulation of intravascularly administered fluorescein isothiocyanate-
labeled high-molecular-weight dextran. Thus, pretreatment with KFG attenuat
es injury in this ex vivo model of VILI via mechanisms that prevent increas
es in permeability.